Cargando…
Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a clinicopathological entity characterized by intrahepatic ectopic steatosis. As a consequence of increased consumption of high-calorie diet and adoption of a sedentary lifestyle, the incidence of NAFLD has surpassed that of viral hepatitis, ma...
Autores principales: | Yan, Bao-Fei, Pan, Lan-Fen, Quan, Yi-Fang, Sha, Qian, Zhang, Jing-Zheng, Zhang, Yi-Feng, Zhou, Li-Bing, Qian, Xi-Long, Gu, Xiao-Mei, Li, Feng-Tao, Wang, Ting, Liu, Jia, Zheng, Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473922/ https://www.ncbi.nlm.nih.gov/pubmed/37664157 http://dx.doi.org/10.3748/wjg.v29.i31.4744 |
Ejemplares similares
-
Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
por: Li, Chun-Xiao, et al.
Publicado: (2019) -
Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction
por: Yang, Yang, et al.
Publicado: (2017) -
Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation
por: Zheng, Lie, et al.
Publicado: (2017) -
Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis
por: Wu, Yi, et al.
Publicado: (2022) -
Systems Pharmacology Based Strategy for Q-Markers Discovery of HuangQin Decoction to Attenuate Intestinal Damage
por: Dai, Xiao-min, et al.
Publicado: (2018)